Psychotic Disorders
|
group |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
101
|
68
|
0.330 |
None |
1.000 |
2 |
|
2011 |
2012 |
Nonorganic psychosis
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
69
|
|
0.330 |
None |
1.000 |
2 |
|
2011 |
2012 |
Schizoaffective Disorder
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
29
|
44
|
0.320 |
None |
1.000 |
2 |
|
2008 |
2010 |
Thrombocythemia, Essential
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
12
|
5
|
0.600 |
None |
0.969 |
2 |
|
2013 |
2020 |
Psychoses, Drug
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
21
|
|
0.300 |
None |
1.000 |
1 |
|
2012 |
2012 |
Paranoid Schizophrenia
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
13
|
|
0.300 |
None |
1.000 |
1 |
|
2008 |
2008 |
Shared Paranoid Disorder
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
3
|
|
0.310 |
None |
1.000 |
1 |
|
2012 |
2012 |
Myocardial Ischemia
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
176
|
|
0.310 |
None |
1.000 |
1 |
|
2005 |
2017 |
Squamous cell carcinoma of esophagus
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
95
|
11
|
0.400 |
None |
1.000 |
1 |
|
2009 |
2020 |
Prostatic Neoplasms
|
group |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
616
|
1
|
0.310 |
None |
1.000 |
1 |
|
2007 |
2009 |
Neoplasm Invasiveness
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Pathologic Function
|
184
|
|
0.300 |
None |
1.000 |
1 |
|
2004 |
2004 |
Myeloproliferative disease
|
group |
Hemic and Lymphatic Diseases
|
Neoplastic Process
|
12
|
10
|
0.500 |
None |
1.000 |
1 |
|
2013 |
2020 |
Melanoma, B16
|
disease |
Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
7
|
|
0.310 |
None |
1.000 |
1 |
|
2006 |
2006 |
Bipolar Disorder
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
477
|
552
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Melanoma, Cloudman S91
|
disease |
Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
7
|
|
0.300 |
None |
1.000 |
1 |
|
2006 |
2006 |
Colorectal Carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
702
|
856
|
0.400 |
None |
0.909 |
1 |
|
2007 |
2020 |
Colorectal Neoplasms
|
group |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
277
|
586
|
0.300 |
None |
1.000 |
1 |
|
2007 |
2007 |
Melanoma, Harding-Passey
|
disease |
Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
7
|
|
0.300 |
None |
1.000 |
1 |
|
2006 |
2006 |
Melanoma, Experimental
|
disease |
Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
7
|
|
0.300 |
None |
1.000 |
1 |
|
2006 |
2006 |
Malignant neoplasm of prostate
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
616
|
281
|
0.400 |
None |
0.923 |
1 |
|
2003 |
2020 |
Hematologic Neoplasms
|
group |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
12
|
13
|
0.430 |
None |
1.000 |
0 |
|
2014 |
2018 |
MYELODYSPLASTIC SYNDROME
|
group |
Hemic and Lymphatic Diseases
|
Neoplastic Process
|
67
|
22
|
0.420 |
None |
1.000 |
0 |
|
2015 |
2020 |
Thrombocytosis, Autosomal Dominant
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
9
|
|
0.300 |
None |
|
0 |
|
|
|
Myelofibrosis
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
4
|
2
|
0.600 |
limited |
0.933 |
2 |
|
2013 |
2020 |
Primary Myelofibrosis
|
disease |
Hemic and Lymphatic Diseases
|
Neoplastic Process
|
6
|
6
|
0.800 |
limited |
0.929 |
2 |
1
|
2013 |
2020 |